Compounds > 1,2,3,4-tetrahydroisoquinoline
Page last updated: 2024-08-17

1,2,3,4-tetrahydroisoquinoline and Central Nervous System Disease

1,2,3,4-tetrahydroisoquinoline has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shah, P; Singh, IP1

Reviews

1 review(s) available for 1,2,3,4-tetrahydroisoquinoline and Central Nervous System Disease

ArticleYear
Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015).
    Expert opinion on therapeutic patents, 2017, Volume: 27, Issue:1

    Topics: Animals; Antineoplastic Agents, Alkylating; Central Nervous System Diseases; Dioxoles; Drug Design; Humans; Neoplasms; Patents as Topic; Tetrahydroisoquinolines; Trabectedin

2017